Merito
Merito is a Japan-incorporated digital platform that connects Japanese university researchers with global corporate R&D teams, BioDAOs, and institutional investors by digitizing Sponsored Research Agreements and tokenizing IP via blockchain, serving Japanese deep tech and biomedical innovators alongside global pharma and crypto-native funders.
- Company typePrivate
- Founded2025
- HeadquartersFukuoka, Japan
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Merito does
Merito K.K. is a Japan-incorporated digital platform company, founded in 2024 and formally established in Fukuoka in March 2025, that connects Japanese deep tech and biomedical researchers with global corporate R&D teams, BioDAOs, and institutional investors. The company digitizes the Sponsored Research Agreement (SRA) workflow — covering discovery, negotiation, e-signature, payment, and ongoing record-keeping — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. Its technology stack combines a web-based project discovery portal, a digital SRA template, and blockchain-based IP-NFT tokenization that enables fractional ownership and programmable revenue sharing via decentralized science (DeSci) infrastructure. The platform is positioned as Japan's primary on-ramp to BioDAO funding communities (VITA DAO, AthenaDAO, ValleyDAO) holding over $2B in aggregate capital.
Merito's business model spans four revenue streams: transaction fees on SRA facilitation between Japanese universities and global pharma/corporate R&D teams, licensing/royalty participation from IP-NFT and DeSci deal structuring, subscription-based investor portal access, and professional services for start-up advisory and curated matchmaking. Pricing is deal-specific rather than standardized, with disclosed project sizes ranging from $120K (Fujislate Cement/Keio) to $200K+ referenced for global corporate partners, well above the $15,000–$25,000 typical of Japanese biopharma sponsorships. The go-to-market is enterprise field sales targeting Japanese universities (Tokyo, Keio, Tsukuba, Kyushu, Nihon) on the supply side and global pharma, BioDAOs, and government agencies on the demand side, supplemented by curated investor trips (e.g., Boston biotech with the Fukuoka Governor's Office) and physical Pop-up Villages (Zō Village, Zō Run Village) that monetize separately as all-inclusive retreats. The company is led by Co-Founder and CEO Brandon Possin, with a Scientific Advisory Council drawn from Takeda Pharma, RIKEN, OIST, SpacePort Japan, and Araya Inc.
Merito firmographics
Firmographics- Name
- Merito
- Legal name
- Merito K.K.
- Website
- https://merito.network
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Merito is a Japan-incorporated digital platform that connects Japanese university researchers with global corporate R&D teams, BioDAOs, and institutional investors by digitizing Sponsored Research Agreements and tokenizing IP via blockchain, serving Japanese deep tech and biomedical innovators alongside global pharma and crypto-native funders.
- Ownership category
- akta.pro rank
Merito industry classification
Industry- Product category
- Research Commercialization Services
- NAICS
- Financial Transactions Processing, Reserve, and Clearinghouse Activities (522320)
- SIC
- Security & Commodity Brokers, Dealers, Exchanges & Services (6200)
- akta.pro primary industry
- Grants, Funding & Budget Allocation Platforms (FSAPAHAE)
- akta.pro secondary industries
- RWA Tokenization Platforms (asset onboarding, structuring, issuance) (FSAPAIAC), DAO Treasury, Governance & On-Chain Finance Tools (FSADAMAL), Coordination & Contributor Management (tasks, bounties, roles) (FSAPAHAD)
Keywords
Where Merito is headquartered
LocationHeadquarters
- HQ city
- Fukuoka
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
Merito business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Sponsored Research Agreement Facilitation: Merito facilitates SRAs between Japanese university researchers and global corporate R&D teams. Researchers gain funding from companies and investors; Merito earns a transaction/facilitation fee from orchestrating the deal (SRA negotiation, e-signing, payment execution, and record maintenance).
- IP Tokenization / DeSci Deal Fees: For DeSci-funded projects, Merito serves as Japan's portal to science DAOs (BioDAOs) and decentralized investment communities. Revenue derives from structuring and facilitating IP-NFT deals that unlock capital from global crypto-native investors and pharma companies.
- Investor Portal Access / Subscription: Merito operates an investor portal where crowd investors access project documentation, scientific white papers, and contribute to Special Purpose Vehicles (SPVs) supporting research IP. The platform enables direct engagement with researchers and distribution of licensing revenue on exit.
- Start-up Advisory and Business Matching: Merito provides curated matchmaking and fundraising advisory to Japanese deep tech start-ups, connecting them with R&D and venture capital partners. The Fukuoka Governor's Office and university spinoffs are specific examples of this advisory revenue stream.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Zō Village: Myoko, Japan (August 2026) — $800/week or $2,000/month pass (plus room supplement), all-inclusive |
| One time/ perpetual license | Pay-as-you-go | Zō Run Village: Kawisari Coffee Plantation, East Java, Indonesia (October 2026) — $350 Early Bird (all-inclusive) |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Merito product offering
Product offeringCore offering
Merito operates a digital platform that connects Japanese university researchers and deep tech startups with global corporate R&D teams, investors, and DeSci funding communities. Its core service is facilitating Sponsored Research Agreements (SRAs) end-to-end — from project discovery and negotiation through e-signing, payment execution, and record maintenance — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. The platform integrates blockchain-based IP tokenization (IP-NFTs) and DAO governance to enable fractional ownership and programmable revenue sharing for research IP.
Product overview
Merito is a digital platform connecting Japan-based deep tech innovators with global capital, consisting of the Merito Network Platform for deal-making and research funding, Pop-up Villages (curated physical retreat communities), and advisory/matching services. The platform enables Sponsored Research Agreements (SRAs) between researchers and investors/corporate R&D teams. Featured projects include Fujislate Cement (sustainable cement production at Keio University), Attune (capillary structure analysis at University of Tokyo), and Fukuoka Governor's Office advisory work connecting Japanese biotech ventures with U.S. investors.
Differentiator
Problem solved
Functional benefit
Products and services
- Merito Network Platform
- Pop-up Villages Curated temporary community retreats designed to remove daily logistics and enable focus on deep work, physical vitality, and human connection. Includes Zō Village (Myoko, Japan) and Zō Run Village (East Java, Indonesia), featuring accommodation, chef-prepared meals, daily classes, workshops on AI/Web3/bio-hacking, and community programming.
- Start-up Advisory Advisory service that boosts a start-up's growth potential and prepares it for global growth and fundraising. Merito works closely with founders to scale their ventures and connect with funding opportunities.
- Curated Matchmaking Tailor-made funding solutions connecting Japanese deep tech innovators with R&D and venture capital partners for traditional financing needs. Provides curated introductions and structured deal-making for startups preferring conventional funding routes.
Quantifiable outcome
- SRA deal time reduced from 4–9 months (traditional) to as little as 3 weeks on Merito's platform
- +5 more outcomes
Companies that use Merito
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles5 records
Merito technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Merito partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Kyoto FusioneeringminorKyoto Fusioneering signed a research agreement on plasma heating with the University of Tsukuba, facilitated through open innovation networks. Merito connects similar Japanese science teams with corporate and international partners for joint R&D agreements.
- Teijin PharmacoreTeijin Pharma invested in Jiksak Bioengineering through a joint research agreement to identify novel drug target genes for neurodegenerative diseases, demonstrating the open innovation model Merito facilitates between Japanese pharma and biotech startups.
- SoftBank / Beyond AI Institute (University of Tokyo)coreSoftBank partnered with the University of Tokyo to form the Beyond AI institute, translating basic and applied AI research for industrial uses. Merito positions itself as a platform that can facilitate similar university-industry partnerships at scale.
- NikoncoreNikon has an array of open innovation funding relationships with University of Tokyo, Osaka University, and Kyoto University. Nikon has also partnered with SBI Bank via the Nikon SBI Innovation Fund to support science funding. Nikon's open innovation model exemplifies the type of partnerships Merito aims to facilitate more broadly.
- Fukuoka Governor's OfficecoreThe Fukuoka Governor's Office hired Merito to make introductions to 11 U.S. biotech investors for five Fukuoka biotech ventures and to plan investment-focused trips to Boston. Merito supported two U.S.-based investment fundraising campaigns for nine Fukuoka biotech start-ups.
- BioLabsminorBioLabs is a co-working laboratory network that has opened facilities in Kawasaki and Tsukuba, Japan, with a new OpenLab planned for Fukuoka in 2025 by Fukuoka Jisho. Merito enables independent Japanese scientists to research in OpenLabs, linking its researcher network with physical lab infrastructure.
- Altos LabsminorU.S.-based Altos Labs funded Kyoto University scientists (notably Nobel laureate Dr. Yamanaka's associates at CIRA). This demonstrates the rare but significant case of foreign investment in Japanese science that Merito aims to make more common.
- DeSci WorldcoreDeSci World builds Proof of Knowledge products and DeSci Nodes — an open-science solution for researchers to publish and manage manuscripts, data, code, and digital research objects. Merito's platform integrates with or leverages similar DeSci infrastructure for blockchain-based IP tokenization.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Merito competitors and assessment
Company assessmentDirect peers
- Molecule: Molecule is the most direct peer: a Web3 platform for IP-NFTs and decentralized funding of early-stage scientific research. Like Merito, it enables tokenization of research IP and connects scientists with global capital via DeSci rails; Merito differentiates by being Japan-focused and adding an SRA facilitation layer.
- VitaDAO: VitaDAO is one of the largest BioDAOs funding longevity research through token-governed IP-NFTs and has partnered with Pfizer. It is a direct comparable as both a BioDAO partner and a competing source of capital/deal flow for research projects Merito is trying to route through Japan.
- ResearchHub: ResearchHub is a web platform that connects researchers and rewards scientific contribution with crypto tokens. It is comparable as a DeSci-adjacent platform facilitating open research collaboration and reward flows, though with a publication/open-science orientation rather than Merito's SRA/IP-tokenization focus.
- LabDAO: LabDAO is a decentralized community coordinating wet-lab research and IP via tokenized contributions. It is comparable as a DeSci platform working to tokenize and coordinate scientific work, and intersects with Merito's IP-NFT and researcher-coordination model.
- Bio Protocol: Bio.xyz (Bio Protocol) is a BioDAO launchpad and DeSci infrastructure layer that incubates and funds decentralized science communities. It is comparable as both DeSci infrastructure Merito integrates with and as a competing platform for spinning up and funding research DAOs.
Emerging players
- ValleyDAO: ValleyDAO is a BioDAO funding synthetic biology research through tokenized IP-NFTs. It is comparable as a listed Merito distribution partner and a parallel DeSci funding community operating in the same tokenized-research model.
- AthenaDAO: AthenaDAO is a BioDAO funding women's reproductive health research via IP-NFTs and DAO governance. It is comparable as a listed Merito distribution partner and a parallel DeSci capital pool targeting specific research verticals.
- CryoDAO: CryoDAO is a BioDAO funding cryopreservation and longevity research through IP-NFTs and DAO governance. It is comparable as a DeSci capital pool operating on the same IP-NFT/DAO rails that Merito channels Japanese researchers toward.
Broad incumbents
- Inpart: Inpart is an established digital platform matching academic IP with corporate R&D teams, with a broad pharma and deep-tech customer base. It is comparable as the conventional, non-DeSci incumbent Merito is disrupting for Japan-to-global research deal flow.
Others
- DeSci Foundation: DeSci Foundation is an ecosystem- and standards-oriented organization promoting decentralized science globally. It is comparable as the broader DeSci ecosystem context in which Merito operates and from which it sources community and capital.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Merito social profiles
Digital presenceMerito financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merito leadership team
Management profileNumber of profiles
Profiles10 records
Merito funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merito M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merito
What does Merito do?
Merito operates a digital platform that connects Japanese university researchers and deep tech startups with global corporate R&D teams, investors, and DeSci funding communities. Its core service is facilitating Sponsored Research Agreements (SRAs) end-to-end — from project discovery and negotiation through e-signing, payment execution, and record maintenance — reducing traditional deal timelines from 4–9 months to as little as 3 weeks. The platform integrates blockchain-based IP tokenization (IP-NFTs) and DAO governance to enable fractional ownership and programmable revenue sharing for research IP.
Is Merito a public or private company?
Merito is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Merito founded?
Merito was founded in 2025. It employs 1 to 10 people.
Where is Merito based?
Merito is headquartered in Fukuoka, Japan, in the Asia region.
How does Merito make money?
Four revenue lines are on record. Sponsored Research Agreement Facilitation is the primary driver. The others are IP Tokenization / DeSci Deal Fees, investor Portal Access / Subscription and start-up Advisory and Business Matching.
Who are Merito's main competitors?
Direct peers on record are Molecule, VitaDAO, ResearchHub, LabDAO and Bio Protocol. Emerging players are ValleyDAO, AthenaDAO and CryoDAO. Inpart is listed as a broad incumbent. DeSci Foundation is listed as an others.
Does Merito have an API?
No public API is recorded for Merito.
What industry is Merito in?
Merito's product category is Research Commercialization Services. Its primary akta.pro industry code is FSAPAHAE, Grants, Funding & Budget Allocation Platforms, with a secondary code of FSAPAIAC, RWA Tokenization Platforms (asset onboarding, structuring, issuance). Its NAICS code is 522320 and its SIC code is 6200.